Literature DB >> 33820981

Exosome-eluting stents for vascular healing after ischaemic injury.

Shiqi Hu1,2, Zhenhua Li1,2, Deliang Shen2, Dashuai Zhu1,2, Ke Huang2, Teng Su1,2, Phuong-Uyen Dinh1,2, Jhon Cores1,2, Ke Cheng3,4.   

Abstract

Drug-eluting stents implanted after ischaemic injury reduce the proliferation of endothelial cells and vascular smooth muscle cells and thus neointimal hyperplasia. However, the eluted drug also slows down the re-endothelialization process, delays arterial healing and can increase the risk of late restenosis. Here we show that stents releasing exosomes derived from mesenchymal stem cells in the presence of reactive oxygen species enhance vascular healing in rats with renal ischaemia-reperfusion injury, promoting endothelial cell tube formation and proliferation, and impairing the migration of smooth muscle cells. Compared with drug-eluting stents and bare-metal stents, the exosome-coated stents accelerated re-endothelialization and decreased in-stent restenosis 28 days after implantation. We also show that exosome-eluting stents implanted in the abdominal aorta of rats with unilateral hindlimb ischaemia regulated macrophage polarization, reduced local vascular and systemic inflammation, and promoted muscle tissue repair.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 33820981      PMCID: PMC8490494          DOI: 10.1038/s41551-021-00705-0

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN: 2157-846X            Impact factor:   25.671


  73 in total

1.  Totally Percutaneous Insertion and Removal of Impella Device Using Axillary Artery in the Setting of Advanced Peripheral Artery Disease.

Authors:  Rajiv Tayal; Mihir Barvalia; Zeshan Rana; Benjamin LeSar; Humayun Iftikhar; Spas Kotev; Marc Cohen; Najam Wasty
Journal:  J Invasive Cardiol       Date:  2016-07-15       Impact factor: 2.022

Review 2.  Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications.

Authors:  Sweta Rani; Aideen E Ryan; Matthew D Griffin; Thomas Ritter
Journal:  Mol Ther       Date:  2015-03-19       Impact factor: 11.454

Review 3.  Current treatment of in-stent restenosis.

Authors:  Fernando Alfonso; Robert A Byrne; Fernando Rivero; Adnan Kastrati
Journal:  J Am Coll Cardiol       Date:  2014-03-13       Impact factor: 24.094

4.  First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent: Angiographic, IVUS, OCT, and Clinical Outcomes From the RevElution Study.

Authors:  Stephen G Worthley; Alexandre Abizaid; Ajay J Kirtane; Daniel I Simon; Stephan Windecker; Sandeep Brar; Ian T Meredith; Sharad Shetty; Ajay Sinhal; Alexandra Popma Almonacid; Daniel Chamié; Akiko Maehara; Gregg W Stone
Journal:  JACC Cardiovasc Interv       Date:  2017-01-23       Impact factor: 11.195

5.  Angiogenesis, vascular endothelial growth factor and platelet-derived growth factor-BB expression, iron deposition, and oxidation-specific epitopes in stented human coronary arteries.

Authors:  J H Bräsen; A Kivelä; K Röser; T T Rissanen; M Niemi; F C Luft; K Donath; S Ylä-Herttuala
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-11       Impact factor: 8.311

6.  Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization.

Authors:  Gaku Nakazawa; Juan F Granada; Carlos L Alviar; Armando Tellez; Greg L Kaluza; Margaret Yoklavich Guilhermier; Sherry Parker; Stephen M Rowland; Frank D Kolodgie; Martin B Leon; Renu Virmani
Journal:  JACC Cardiovasc Interv       Date:  2010-01       Impact factor: 11.195

Review 7.  Titanium-nitride-oxide-coated coronary stents: insights from the available evidence.

Authors:  Pasi P Karjalainen; Wail Nammas
Journal:  Ann Med       Date:  2016-11-12       Impact factor: 4.709

8.  Wound Healing Outcomes and Health-Related Quality-of-Life Changes in the ACHILLES Trial: 1-Year Results From a Prospective Randomized Controlled Trial of Infrapopliteal Balloon Angioplasty Versus Sirolimus-Eluting Stenting in Patients With Ischemic Peripheral Arterial Disease.

Authors:  Konstantinos Katsanos; Stavros Spiliopoulos; Athanasios Diamantopoulos; Dimitris Siablis; Dimitris Karnabatidis; Dierk Scheinert
Journal:  JACC Cardiovasc Interv       Date:  2016-01-06       Impact factor: 11.195

Review 9.  Novel markers of peripheral arterial disease.

Authors:  Farhan J Khawaja; Iftikhar J Kullo
Journal:  Vasc Med       Date:  2009-11       Impact factor: 3.239

10.  Some design considerations for polymer-free drug-eluting stents: a mathematical approach.

Authors:  Sean McGinty; Tuoi T N Vo; Martin Meere; Sean McKee; Christopher McCormick
Journal:  Acta Biomater       Date:  2015-02-21       Impact factor: 8.947

View more
  14 in total

1.  A New Role for Extracellular Vesicles in Cardiac Tissue Engineering and Regenerative Medicine.

Authors:  Karl T Wagner; Milica Radisic
Journal:  Adv Nanobiomed Res       Date:  2021-06-24

2.  Role of Cardiomyocyte-Derived Exosomal MicroRNA-146a-5p in Macrophage Polarization and Activation.

Authors:  Cong Chen; Sidong Cai; Min Wu; Run Wang; Mingya Liu; Gaozhen Cao; Min Dong; Kai-Hang Yiu
Journal:  Dis Markers       Date:  2022-05-02       Impact factor: 3.464

Review 3.  Role of Extracellular Vesicles as Potential Diagnostic and/or Therapeutic Biomarkers in Chronic Cardiovascular Diseases.

Authors:  Jose Luis Martin-Ventura; Carmen Roncal; Josune Orbe; Luis Miguel Blanco-Colio
Journal:  Front Cell Dev Biol       Date:  2022-01-26

4.  Nidogen1-enriched extracellular vesicles accelerate angiogenesis and bone regeneration by targeting Myosin-10 to regulate endothelial cell adhesion.

Authors:  Pengzhen Cheng; Tianqing Cao; Xueyi Zhao; Weiguang Lu; Sheng Miao; Fenru Ning; Dong Wang; Yi Gao; Long Wang; Guoxian Pei; Liu Yang
Journal:  Bioact Mater       Date:  2021-10-27

5.  Bioinspired porous microspheres for sustained hypoxic exosomes release and vascularized bone regeneration.

Authors:  Yike Gao; Zuoying Yuan; Xiaojing Yuan; Zhuo Wan; Yingjie Yu; Qi Zhan; Yuming Zhao; Jianmin Han; Jianyong Huang; Chunyang Xiong; Qing Cai
Journal:  Bioact Mater       Date:  2022-02-01

6.  Engineering stem cells to produce exosomes with enhanced bone regeneration effects: an alternative strategy for gene therapy.

Authors:  Feiyang Li; Jun Wu; Daiye Li; Liuzhi Hao; Yanqun Li; Dan Yi; Kelvin W K Yeung; Di Chen; William W Lu; Haobo Pan; Tak Man Wong; Xiaoli Zhao
Journal:  J Nanobiotechnology       Date:  2022-03-15       Impact factor: 10.435

7.  Augmented cellular uptake and homologous targeting of exosome-based drug loaded IOL for posterior capsular opacification prevention and biosafety improvement.

Authors:  Siqing Zhu; Huiying Huang; Dong Liu; Shimin Wen; Liangliang Shen; Quankui Lin
Journal:  Bioact Mater       Date:  2022-02-26

Review 8.  Bioengineering Technologies for Cardiac Regenerative Medicine.

Authors:  Mira Chingale; Dashuai Zhu; Ke Cheng; Ke Huang
Journal:  Front Bioeng Biotechnol       Date:  2021-06-03

9.  Platelet membrane and stem cell exosome hybrid enhances cellular uptake and targeting to heart injury.

Authors:  Shiqi Hu; Xianyun Wang; Zhenhua Li; Dashuai Zhu; Jhon Cores; Zhenzhen Wang; Junlang Li; Xuan Mei; Xiao Cheng; Teng Su; Ke Cheng
Journal:  Nano Today       Date:  2021-06-08       Impact factor: 18.962

Review 10.  Applying Principles of Regenerative Medicine to Vascular Stent Development.

Authors:  Prakash Parthiban Selvakumar; Michael Scott Rafuse; Richard Johnson; Wei Tan
Journal:  Front Bioeng Biotechnol       Date:  2022-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.